• Dr. Sandip Mali
• Dr. Shweta Deolekar
• Dr. Poorva Sawant
• Dr. Gayatri Ganu

Type 2 Diabetes Mellitus (T2DM) remains a major global health concern, with conventional therapies often presenting limitations in addressing the root cause. Ayurvedic therapies have shown promising potential in diabetes prevention and management. This retrospective, observational 12-week study evaluated the effectiveness of the True Diabetes Reversal Program (TDRP), a holistic regimen aimed at improving glycaemic control by targeting the underlying causes and promoting cellular repair. The primary outcome was the change in glycaemic parameters including HbA1c, fasting plasma glucose (FPG), and post-prandial plasma glucose (PPG). The study also assessed the proportion of patients achieving at least a 1% reduction in HbA1c and compared outcomes in diabetic and prediabetic subgroups. A total of 69% of patients achieved an HbA1c level of ≤7.0%, and 38.1% reached ≤5.7%. HbA1c was significantly reduced (p<0.0001), with 57% of patients showing at least a 1% drop. FPG improved significantly (p=0.007 overall; p=0.004 in diabetics), while both diabetics and prediabetics showed significant reductions in HbA1c (p=0.001). Furthermore, 26.2% of patients achieved target levels for both FPG and PPG. The highest mean reduction was observed in HbA1c (17.1%), followed by FPG (16.3%) and PPG (9.9%). TDRP demonstrated meaningful improvements in glycaemic control, suggesting its effectiveness in managing newly diagnosed and uncontrolled T2DM.

True Diabetes Reversal Program, Type 2 Diabetes Mellitus, Fasting Plasma Glucose, Post-Prandial Plasma Glucose, Glycated Hemoglobin

"Effectiveness of True Diabetes Reversal Program (TDRP) In Type-2 Diabetes Mellitus (T2DM): A Multicenter, Retrospective, Observational Study", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 4, page no.m735-m742, April-2025, Available :http://www.jetir.org/papers/JETIR2504C94.pdf

"Effectiveness of True Diabetes Reversal Program (TDRP) In Type-2 Diabetes Mellitus (T2DM): A Multicenter, Retrospective, Observational Study", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 4, page no. ppm735-m742, April-2025, Available at : http://www.jetir.org/papers/JETIR2504C94.pdf